Rhabdomyolysis Diagnosis and Management

Diagnostic Criteria

Rhabdomyolysis is defined as muscle symptoms with marked CK elevation (typically substantially greater than 10 times the upper limit of normal) and with creatinine elevation, as defined by the American College of Cardiology/American Heart Association/NHLBI 1, 2
Diagnostic threshold is at least 10 times the upper limit of normal for serum creatine kinase (CK) levels, as recommended by the American College of Emergency Physicians 3, 4, 5

Myalgia is characterized by muscle ache/weakness without CK elevation, whereas myositis is characterized by muscle symptoms with increased CK levels, but typically not exceeding 10x ULN, in contrast to rhabdomyolysis which is characterized by muscle symptoms with marked CK elevation (>10x ULN) and evidence of renal involvement 1, 2
Inflammatory markers are typically higher in myositis, and autoantibody testing may be needed to differentiate from rhabdomyolysis, according to the American College of Rheumatology 6

Statins can cause myopathy and severe rhabdomyolysis, especially at higher doses or when combined with other medications, with a strength of evidence based on multiple studies, as noted by the American College of Cardiology 2, 1
Certain medications like fibrates, cyclosporine, macrolide antibiotics, and certain antifungal drugs may increase the risk of rhabdomyolysis when combined with statins, as acknowledged by the American Heart Association 2, 1
Red yeast rice supplements (containing lovastatin) and certain dietary supplements such as Hydroxycut may contribute to rhabdomyolysis, as reported in the American Journal of Kidney Diseases 7

Diagnosis of rhabdomyolysis involves monitoring serum creatine kinase (CK) levels, which can peak 24-72 hours after muscle injury, and urinalysis for myoglobinuria, as recommended by the American College of Emergency Physicians 3, 4, 5
Plasma myoglobin confirms muscle breakdown, but has a shorter half-life (approximately 2-3 hours), and may return to normal while CK remains elevated, with the classic triad of myalgia, muscle weakness, and pigmenturia present in less than 10% of cases 3, 5
Checking serum electrolytes, urea nitrogen, and creatinine during treatment, with an electrocardiogram to assess for cardiac complications and effects of electrolyte abnormalities, is recommended by the American College of Cardiology and Circulation guideline 8, 9, 10

Aggressive hydration is crucial to prevent acute kidney injury, with the goal of achieving diuresis greater than 300 mL/hour, using isotonic saline as the initial fluid of choice, and avoiding potassium-containing fluids, as recommended by the European Renal Association and American College of Cardiology 10, 11, 12, 13, 4
Monitor and correct hyperkalemia urgently if present, and address hypocalcemia if symptomatic, with nephrology consultation recommended for all cases with acute kidney injury, and renal replacement therapy considered for severe hyperkalemia, acidosis, volume overload, or uremic symptoms, as suggested by the National Kidney Foundation and American College of Nephrology 10, 14, 3, 12
Fasciotomy is indicated in patients with hypotensive patients with intracompartment pressures ≥20 mmHg, uncooperative/unconscious patients with pressures ≥30 mmHg, and normotensive patients with positive clinical findings and pressures ≥30 mmHg, with benefits decreasing significantly if delayed beyond 8 hours, according to the American Academy of Orthopaedic Surgeons and the American Society of Anesthesiologists 5, 3

Proper training during transition periods, limiting volume and intensity of activity, and avoiding "too much, too soon, too fast" in workout regimens can prevent exertional rhabdomyolysis, with venue-specific emergency action plans, as recommended by the American College of Sports Medicine 11
Maintaining adequate hydration, especially during exercise, and avoiding all nephrotoxic medications, including NSAIDs, ACE inhibitors/ARBs, and certain antibiotics, can prevent rhabdomyolysis, as recommended by the Nature Reviews Nephrology and American College of Nephrology 13

Patients with recurrent rhabdomyolysis or suspected genetic cause should undergo detailed family history taking and consideration of specific genetic panels for conditions such as glycogen storage diseases, fatty acid oxidation disorders, and mitochondrial disorders, with the aim of identifying underlying genetic predispositions, as recommended by the American College of Cardiology 4, 15
Genetic counseling is recommended for patients with confirmed genetic diagnosis, and family screening should be performed when hereditary disorder is identified, as recommended by the American College of Cardiology 15